BENEFIT OF SORAFENIB ACCORDING TO UNDERLYING LIVER DISEASE ETIOLOGY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

被引：0
|
作者：
Bouattour, M. [1 ]
Goutte, N. [1 ]
Vullierme, M. -P. [2 ]
Castelnau, C. [1 ]
Farges, O. [3 ]
Faivre, S. [4 ]
Durand, F. [1 ]
Castera, L. [1 ]
机构：
[1] Beaujon Hosp, AP HP, Hepatol, Clichy, France
[2] Beaujon Hosp, AP HP, Radiol, Clichy, France
[3] Beaujon Hosp, AP HP, Surg, Clichy, France
[4] Beaujon Hosp, AP HP, Oncol, Clichy, France
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61158-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P998
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [1] Influence of underlying liver disease on response to sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Bouattour, M.
    Faivre, S. J.
    Dreyer, C.
    Paradis, V.
    Raymond, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [2] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
    Alves, Rogerio C.
    Alves, Daniele E.
    Guz, Betty
    Viana, Monica V.
    Harriz, Michelle C.
    Matos, Carla A.
    Terrabuio, Deborah
    Chagas, Aline
    Moutinho, Renata D.
    Taddeo, Eliane F.
    Duarte, Kelly C.
    Oliveira, George P.
    Ribeirol, Juliana M.
    Kondo, Mario
    Gampel, Otavio
    Poletti, Paula
    HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
  • [3] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
    Feun, L. G.
    Levi, D.
    Moon, J.
    Nishida, S.
    Island, E.
    Selvaggi, G.
    Martin, P.
    Savaraj, N.
    Mendes, F.
    Tzakis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] EXPERIENCE IN THE USE O SORAFENIB FOR TREATMENT OF HEPATOCELLULAR CARCINOMA IN (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE IN 3 BRAZILIANS CENTERS
    Alves, Rogerio
    Alves, Daniele E.
    Harriz, Michelle C.
    Viana, Monica V.
    Kondo, Mario
    Terrabuio, Deborah
    Brandalise, Renata
    Chagas, Aline
    Linhares, Livia M.
    Costa, Daniel P.
    Matos, Carla A.
    Baia, Carlos
    Gampell, Otavio
    Poletti, Paula B.
    HEPATOLOGY, 2011, 54 : 1421A - 1422A
  • [5] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitrios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, M. H. Ruhe
    Papadatos-Pastos, Dionysios
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [6] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitris
    Thillai, Kiruthikah
    Papadatos-Pastos, Dionysios
    Chowdhury, Mahfuja Hussain Ruhe
    Korantzis, Ippokratis
    Manickavasagar, Thubeena
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology
    Nagai, Hidenari
    Mukozu, Takanori
    Kobayashi, Kojiro
    Amanuma, Makoto
    Yoshimine, Naoyuki
    Ogino, Yu
    Matsui, Daigo
    Daido, Yasuko
    Matsukiyo, Yasushi
    Matsui, Teppei
    Wakui, Noritaka
    Momiyama, Koichi
    Shinohara, Mie
    Higai, Koji
    Igarashi, Yoshinori
    ANTICANCER RESEARCH, 2019, 39 (04) : 2183 - 2191
  • [8] US GIDEON Final Analysis: Evaluation of Patient and Disease Characteristics, and Sorafenib Safety in Hepatocellular Carcinoma (HCC) Patients with Advanced Liver Disease
    Gholam, Pierre M.
    Cohn, Allen
    El-Khoueiry, Anthony
    Geschwind, Jean-Francois H.
    Goldenberg, Alec
    Marrero, Jorge A.
    Martin, Robert
    McGuire, Brendan M.
    Miksad, Rebecca A.
    Piperdi, Bilal
    Sanyal, Arun J.
    Venook, Alan
    Germino, Joseph F.
    Mantry, Parvez S.
    HEPATOLOGY, 2013, 58 : 1225A - 1226A
  • [9] Comparative efficacy of sorafenib dose in patients with advanced hepatocellular carcinoma (HCC) with varying liver dysfunction.
    Patel, Sukeshi R.
    Al-Rajabi, Raed Moh'd Taiseer
    Ketchum, Norma
    Lu, Ting-Wei
    Pollock, Brad H.
    Michalek, Joel
    Mahalingam, Devalingam
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis
    Schuette, Kerstin
    Zimmermann, Lars
    Bornschein, Jan
    Csepregi, Antal
    Ruehl, Ricarda
    Ricke, Jens
    Malfertheiner, Peter
    DIGESTION, 2011, 83 (04) : 275 - 282
12345